(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,10R,12R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
CAS : 63223-86-9
Ref. IN-DA00IB69
| 20mg | Arrêté |
Informations sur le produit
Nom :
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,10R,12R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonymes :
- [u'ginsenoside G-Rh(1)', u'ginsenoside Rh(1)', u'ginsenoside Rh1', u'Ginsenoside Rh1', u'63223-86-9', u'20(S)-Ginsenoside Rh1', u'MFCD09951797', u'ginsenoside-Rh1', u'Sanchinoside B2', u'C36H62O9', u'Prosapogenin A2', u'(3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-en-6-yl beta-D-glucopyranoside', u'20-s-ginsenoside-rh1', u'GINSENOSIDE RH 1', u'UNII-XBR6F7G8FU', u'(20S)-ginsenoside Rh1', u'XBR6F7G8FU', u'BIDD:ER0183', u'CHEMBL466844', u'CHEBI:142487', u'(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol', u'HY-N0604', u'BDBM50023447', u'Ginsenoside Rh1, analytical standard', u'ZINC49852137', u'AKOS025311542', u'CS-3834', u'O581', u'A834283', u'Q-100729', u'(3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-en-6-yl-beta-D-glucopyranoside', u'(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-oxidanyl-hept-5-en-2-yl]-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]oxane-3,4,5-', u'GinsenosideRh1', u'ginsenoside Rh(1)', u'ginsenoside G-Rh(1)', u'ACN-047137', u'C36-H62-O9', u'C425564']
- (3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-en-6-yl beta-D-glucopyranoside
- (3beta,6alpha,9xi,12beta,13xi)-3,12,20-trihydroxydammar-24-en-6-yl beta-D-glucopyranoside
- (3β,6α,12β)-3,12,20-Trihydroxydammar-24-en-6-yl β-<span class="text-smallcaps">D</span>-glucopyranoside
- 20(S)-Ginsenoside Rh<sub>1</sub>
- Dammarane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
- Ginsenoside Rh<sub>1</sub>
- Prosapogenin A<sub>2</sub>
- Rh1 ginsenoside
- Rh<sub>1</sub> ginsenoside
- Voir d'autres synonymes
- S-Ginsenoside Rh<sub>1</sub>
- Sanchinoside B<sub>2</sub>
- Sanchinoside Rh1
- Sanchinoside Rh<sub>1</sub>
- β-<span class="text-smallcaps">D</span>-Glucopyranoside, (3β,6α,12β)-3,12,20-trihydroxydammar-24-en-6-yl
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
638.8721
Formule :
C36H62O9
Degré de pureté :
98%
InChI :
InChI=1S/C36H62O9/c1-19(2)10-9-13-36(8,43)20-11-15-34(6)26(20)21(38)16-24-33(5)14-12-25(39)32(3,4)30(33)22(17-35(24,34)7)44-31-29(42)28(41)27(40)23(18-37)45-31/h10,20-31,37-43H,9,11-18H2,1-8H3/t20-,21+,22-,23+,24+,25-,26-,27+,28-,29+,30-,31+,33+,34+,35+,36-/m0/s1
Code InChI :
RAQNTCRNSXYLAH-RFCGZQMISA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
